MLPX: Higher Dividends And Better Comps Make This Midstream ETF A Buy (NYSEARCA:MLPX)
MLPX: Higher Dividends And Better Comps Make This Midstream ETF A Buy (Rating Upgrade)
Source link
MLPX: Higher Dividends And Better Comps Make This Midstream ETF A Buy (Rating Upgrade)
Source link
Keefe, Bruyette & Woods upgraded Zillow Group to a “hold” rating in a research report on Friday. Source link
ET Intelligence Group: The Reserve Bank of India’s (RBI) draft norms aimed at curbing mis-selling of financial products could weigh more heavily on the private sector banks given their higher reliance on insurance income. According to the data collated by ETIG from annual reports, the share of insurance income in the other income for the…
If you’re searching for a high-yield dividend stock that pays you like clockwork while trading at a jaw-dropping discount, check out Primaris Real Estate Investment Trust (TSX: PMZ.UN). With a juicy 5.8% monthly distribution yield and a history of raising payouts, this Canadian REIT isn’t just another passive income investment. It’s a rare trifecta of…
January 3, 2025January 3, 2025 Smartworks, the managed workspace provider that is about to go public, has leased approximately 4.7 lakh square feet of office space in the DLF Commercial Building at DLF City-V in Gurugram for an annual rent of Rs 94 crore, according to records obtained by…
The 2024 December quarter results for gold producers pointed to bumper performance, causing gold stocks to renew their rally. Given gold’s rally has lasted this long, could there be more upside? Find out from our resident gold and precious metals investment expert, Brian Chu, why he believes there could be more to come and what…
NEW DELHI: The Nifty Pharma index closed on a positive note on Monday. Shares of Divi’s Laboratories Ltd.(up 3.92 per cent), Dr. Reddy’s Laboratories Ltd.(up 0.88 per cent), Ajanta Pharma Ltd.(up 0.67 per cent), Biocon Ltd.(up 0.49 per cent) and Zydus Lifesciences Ltd.(up 0.47 per cent) ended the day as top gainers in the pack….